1. Patients with Advanced Ovarian Cancer Administered Oral Etoposide following Taxane as Maintenance Chemotherapy
   Hiroaki Nagano et al, 2016, Case Reports in Oncology CrossRef
2. Breast Cancer and Chronic Lymphocytic Leukemia and Renal Cell Carcinoma: A Case Report of a Rare Cancer Combination
   Camellia Akhgarjand et al, 2024, Case Reports in Oncology CrossRef
3. How breast cancer chemotherapy increases the risk of leukemia: Thoughts about a case of diffuse large B-cell lymphoma and leukemia after breast cancer chemotherapy
   Bin Zhang et al, 2016, Cancer Biology & Therapy CrossRef
4. Oral Etoposide for Refractory and Relapsed Neuroblastoma
   Brian H. Kushner et al, 1999, Journal of Clinical Oncology CrossRef
5. Long-Term Follow-up of a Randomized Study of Oral Etoposide versus Viscum album Fermentatum Pini as Maintenance Therapy in Osteosarcoma Patients in Complete Surgical Remission after Second Relapse
   Alessandra Longhi et al, 2020, Sarcoma CrossRef
6. Formulation of Piperine–Chitosan-Coated Liposomes: Characterization and In Vitro Cytotoxic Evaluation
   Syed Sarim Imam et al, 2021, Molecules CrossRef
7. Phase I Study of Paclitaxel, Carboplatin, and Increasing Days of Prolonged Oral Etoposide in Ovarian, Peritoneal, and Tubal Carcinoma: A Gynecologic Oncology Group Study
   Peter G. Rose et al, 2000, Journal of Clinical Oncology CrossRef